PHARMACEUTICAL COMPOSITIONS COMPRISING GLP-1 PEPTIDES OR EXENDIN-4 AND A BASAL INSULIN PEPTIDE

摘要

Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.